CLINICAL TRIALS AND OBSERVATIONS Residual disease detected by multidimensional flow cytometry signifies high relapse risk in patients with de novo acute myeloid leukemia: a report from Children’s Oncology Group
نویسندگان
چکیده
1Hematologics Inc, Seattle, WA; 2University of Southern California, Los Angeles, CA; 3Children’s Oncology Group, Arcadia, CA; 4Fundaleu Hospital, Buenos Aires, Argentina; 5St Jude Children’s Research Hospital, Memphis, TN; 6University of Minnesota, Minneapolis, MN; 7Fred Hutchinson Cancer Research Center, Seattle, WA; 8Department of Pediatrics, University of Washington, Seattle, WA; 9Amgen Incorporated, Thousand Oaks, CA; 10Aflac Cancer Center and Blood Disorders Service/Children’s Healthcare of Atlanta/Emory University, Atlanta, GA; and 11Children’s Mercy Hospital and Clinics, Kansas City, MO
منابع مشابه
CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS Amount of spontaneous apoptosis detected by Bax/Bcl-2 ratio predicts outcome in acute myeloid leukemia (AML)
The inability to undergo apoptosis is a crucial mechanism of multidrug resistance in acute myeloid leukemia (AML), and the analysis of mitochondrial apoptotic proteins may represent a significant prognostic tool to predict outcome. Bcl-2 and Bax oncoproteins were evaluated in 255 de novo AML patients (pts) by flow cytometry using an anti–bcl-2 monoclonal antibody (MoAb) and an anti-bax MoAb. Th...
متن کاملCLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS Biology and outcome of childhood acute megakaryoblastic leukemia: a single institution’s experience
To describe the clinical and biologic features of pediatric acute megakaryoblastic leukemia (AMKL) and to identify prognostic factors, experience at St Jude Children’s Research Hospital was reviewed. Of 281 patients with acute myeloid leukemia treated over a 14-year period, 41 (14.6%) had a diagnosis of AMKL. Six patients had Down syndrome and AMKL, 6 had secondary AMKL, and 29 had de novo AMKL...
متن کاملCLINICAL TRIALS AND OBSERVATIONS Identification of distinct prognostic subgroups in low- and intermediate-1–risk myelodysplastic syndromes by flow cytometry
The World Health Organization (WHO) classification contributes to refined classification and prognostication of myelodysplastic syndromes (MDSs). Flow cytometry might add significantly to diagnostic and prognostic criteria. Our analysis of bone marrow samples from 50 patients with MDS showed aberrant expression of differentiation antigens in the myelomonocytic lineage. This also accounted for r...
متن کاملCLINICAL TRIALS AND OBSERVATIONS Minimally differentiated acute myeloid leukemia (FAB AML-M0) is associated with an adverse outcome in children: a report from the Children’s Oncology Group, studies CCG-2891 and CCG-2961
1Division of Hematology/Oncology/BMT, BC’s Children’s Hospital, Vancouver, BC, Canada; 2Department of Preventive Medicine, University of Southern California, Los Angeles; 3Children’s Oncology Group, Arcadia, CA; 4Fred Hutchinson Cancer Research Center, Seattle, WA; 5Department of Pathology, Ohio State University, Columbus; 6Division of Pediatric Hematology/Oncology, IWK Health Center, Halifax, ...
متن کاملCLINICAL TRIALS AND OBSERVATIONS Minimal residual disease monitoring by quantitative RT-PCR in core binding factor AML allows risk stratification and predicts relapse: results of the United Kingdom MRC AML-15 trial
The clinical value of serial minimal residual disease (MRD) monitoring in core binding factor (CBF) acute myeloid leukemia (AML) by quantitative RT-PCR was prospectively assessed in 278 patients [163 with t(8;21) and 115 with inv(16)] entered in the United Kingdom MRC AML 15 trial. CBF transcripts were normalized to 105 ABL copies. At remission, after course 1 induction chemotherapy, a > 3 log ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2012